Cardio-Metabolic Risk and Aspirin: What Does the Evidence Say for Indian Patients?
India carries a heavy cardiometabolic burden of nearly 30%, intensified by early-onset diabetes, hypertension, dyslipidaemia, and obesity patterns that extend beyond BMI. Among Indians with metabolically obese non-obese (MONO) and…